Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome.

@article{Vlagea2013AntiphosphatidylserineprothrombinA,
  title={Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome.},
  author={Alexandru Vlagea and Antonio A Gil and Mar{\'i}a V Cuesta and Florencia Arribas and J de M D{\'i}ez and Paz Lavilla and Dora Pascual-Salcedo},
  journal={Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis},
  year={2013},
  volume={19 3},
  pages={289-96}
}
The antiphospholipid antibodies present in antiphospholipid syndrome (APS) are directed at a number of phospholipid-binding proteins: β2 glycoprotein I (β2GPI), prothrombin, and so on. Antibodies directed at β2GPI are accepted as a classification criterion for APS, while the presence of antiprothrombin antibodies is not. In the present article, we investigated the possible role of antiphosphatidylserine/prothrombin antibodies (aPS/PT) as marker of APS on a cohort of 295 individuals with APS (95… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

The presence of anti-phosphatidylserine/prothrombin antibodies as a risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus

  • J Nojima, I Yoshinori, E Suehisa, H Kuratsune, Y. Kanakura
  • Haematologica
  • 2006
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…